Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 2 |
2021 | 2 |
2022 | 2 |
2023 | 1 |
2024 | 1 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Future Challenges in Cancer Resistance to Immunotherapy.
Cancers (Basel). 2020 Apr 10;12(4):935. doi: 10.3390/cancers12040935.
Cancers (Basel). 2020.
PMID: 32290124
Free PMC article.
Review.
Invasive margin tissue-resident macrophages of high CD163 expression impede responses to T cell-based immunotherapy.
van Elsas MJ, Labrie C, Etzerodt A, Charoentong P, van Stigt Thans JJC, Van Hall T, van der Burg SH.
van Elsas MJ, et al.
J Immunother Cancer. 2023 Mar;11(3):e006433. doi: 10.1136/jitc-2022-006433.
J Immunother Cancer. 2023.
PMID: 36914207
Free PMC article.
Item in Clipboard
Immunotherapy-activated T cells recruit and skew late-stage activated M1-like macrophages that are critical for therapeutic efficacy.
van Elsas MJ, Middelburg J, Labrie C, Roelands J, Schaap G, Sluijter M, Tonea R, Ovcinnikovs V, Lloyd K, Schuurman J, Riesenfeld SJ, Gajewski TF, de Miranda NFCC, van Hall T, van der Burg SH.
van Elsas MJ, et al.
Cancer Cell. 2024 May 16:S1535-6108(24)00135-1. doi: 10.1016/j.ccell.2024.04.011. Online ahead of print.
Cancer Cell. 2024.
PMID: 38759656
Free article.
Item in Clipboard
IL-6 signaling in macrophages is required for immunotherapy-driven regression of tumors.
Beyranvand Nejad E, Labrie C, van Elsas MJ, Kleinovink JW, Mittrücker HW, Franken KLMC, Heink S, Korn T, Arens R, van Hall T, van der Burg SH.
Beyranvand Nejad E, et al. Among authors: van elsas mj.
J Immunother Cancer. 2021 Apr;9(4):e002460. doi: 10.1136/jitc-2021-002460.
J Immunother Cancer. 2021.
PMID: 33879600
Free PMC article.
Item in Clipboard
Regulatory T Cell Depletion Using a CRISPR Fc-Optimized CD25 Antibody.
van Elsas MJ, van der Schoot JMS, Bartels A, Steuten K, van Dalen D, Wijfjes Z, Figdor CG, van Hall T, van der Burg SH, Verdoes M, Scheeren FA.
van Elsas MJ, et al.
Int J Mol Sci. 2022 Aug 5;23(15):8707. doi: 10.3390/ijms23158707.
Int J Mol Sci. 2022.
PMID: 35955841
Free PMC article.
Item in Clipboard
NKG2A is a late immune checkpoint on CD8 T cells and marks repeated stimulation and cell division.
Borst L, Sluijter M, Sturm G, Charoentong P, Santegoets SJ, van Gulijk M, van Elsas MJ, Groeneveldt C, van Montfoort N, Finotello F, Trajanoski Z, Kiełbasa SM, van der Burg SH, van Hall T.
Borst L, et al. Among authors: van elsas mj.
Int J Cancer. 2022 Feb 15;150(4):688-704. doi: 10.1002/ijc.33859. Epub 2021 Nov 10.
Int J Cancer. 2022.
PMID: 34716584
Free PMC article.
Item in Clipboard
Lack of myeloid cell infiltration as an acquired resistance strategy to immunotherapy.
Beyranvand Nejad E, Labrie C, Abdulrahman Z, van Elsas MJ, Rademaker E, Kleinovink JW, van der Sluis TC, van Duikeren S, Teunisse AFAS, Jochemsen AG, Oosting J, de Miranda NFCC, Van Hall T, Arens R, van der Burg SH.
Beyranvand Nejad E, et al. Among authors: van elsas mj.
J Immunother Cancer. 2020 Sep;8(2):e001326. doi: 10.1136/jitc-2020-001326.
J Immunother Cancer. 2020.
PMID: 32873723
Free PMC article.
Item in Clipboard
Cite
Cite